merscov
strain
provid
depart
virosci
erasmu
medic
center
rotterdam
netherland
viru
propag
vero
cell
cultur
dulbecco
modifi
eagl
medium
invitrogen
carlsbad
ca
usa
supplement
fetal
bovin
serum
mmoll
glutamin
uml
penicillin
streptomycin
three
nativeborn
adult
male
dromedari
camel
camelu
dromedariu
obtain
privat
sale
anim
test
neg
neutral
assay
merscov
bovin
coronaviru
elisa
camel
year
old
respect
camel
intact
male
camel
castrat
anim
hous
anim
biosafeti
level
facil
durat
experi
fed
ad
libitum
camel
acclim
facil
week
viru
inocul
sedat
camel
xylazin
inocul
total
dose
tissu
cultur
infect
dose
merscov
strain
total
volum
ml
way
intratrach
ml
use
transcutan
cathet
intranas
ml
nostril
expuls
syring
conjunctiv
ml
conjunctiv
sac
rout
rout
inocul
infecti
dose
chosen
reflect
combin
like
rout
exposur
increas
potenti
infect
anim
observ
least
daili
durat
experi
behavior
food
consumpt
activ
level
nasal
discharg
rectal
temperatur
taken
daili
day
postinocul
weekli
anim
euthan
nasal
oral
swab
sampl
fecal
sampl
collect
viru
transport
medium
viru
lysi
buffer
daili
day
postinocul
dpi
weekli
anim
euthan
blood
collect
evacu
edta
serumsepar
tube
daili
dpi
weekli
thereaft
urin
collect
conveni
necropsi
evalu
whether
viru
exhal
infect
camel
funnel
place
muzzl
camel
connect
vacuum
pump
captur
exhal
air
tissu
cultur
media
ml
dulbecco
modifi
eagl
medium
fetal
bovin
serum
antifoam
glass
imping
ace
glass
inc
vineland
nj
usa
exhal
breath
collect
minut
analyz
quantit
realtim
pcr
qpcr
viru
titrat
day
camel
respect
euthan
sampl
collect
nasal
turbin
lung
trachea
larynx
pharynx
liver
spleen
kidney
bladder
urin
duodenum
jejunum
colon
rectum
abomasum
forestomach
prescapular
lymph
node
retropharyng
lymph
node
tracheobronchi
lymph
node
mediastin
lymph
node
mesenter
lymph
node
medulla
olfactori
cortex
extract
rna
swab
sampl
fecal
sampl
serum
sampl
use
qiaamp
viral
rna
kit
qiagen
valencia
ca
usa
accord
manufactur
instruct
detect
viral
rna
use
rna
onestep
realtim
revers
transcript
pcr
upe
assay
use
rotorgenetm
probe
kit
qiagen
accord
manufactur
instruct
standard
dilut
titer
viru
stock
run
parallel
calcul
equival
sampl
titrat
swab
sampl
viral
transport
medium
whole
blood
homogen
tissu
wtvol
merscov
viru
plaqu
assay
briefli
serial
dilut
sampl
prepar
medium
mem
bovin
serum
albumin
mgl
sodium
bicarbon
mm
tri
ph
mgl
phenol
red
contain
mg
gentamicin
u
penicillin
g
mg
streptomycin
mg
amphotericinl
plaqu
assay
conduct
describ
west
nile
viru
plaqu
count
day
second
overlay
viru
titer
express
pfu
per
ml
gram
determin
neutral
antibodi
titer
plaqu
reduct
neutral
test
describ
use
neutral
cutoff
tissu
fix
day
neutralbuff
formalin
embed
paraffin
tissu
section
stain
hematoxylin
eosin
detect
merscov
antigen
complet
immunohistochem
test
use
rabbit
polyclon
antiserum
primari
antibodi
camel
show
minor
clinic
sign
diseas
consist
rhinorrhea
figur
panel
mild
elev
bodi
temperatur
dpi
dpi
figur
panel
b
clinic
sign
observ
rhinorrhea
develop
camel
begin
camel
camel
dpi
persist
week
nasal
discharg
drain
nare
vari
charact
serou
purul
minor
hemorrhag
observ
occas
may
caus
trauma
occur
collect
sampl
merscov
shed
start
dpi
detect
presenc
infecti
viru
viral
rna
qpcr
nasal
swab
sampl
infecti
viru
shed
detect
dpi
shed
viral
rna
detect
dpi
nasal
swab
sampl
figur
low
concentr
infecti
viru
viral
rna
detect
oral
sampl
like
origin
drainag
nasal
caviti
figur
viral
rna
detect
fecal
sampl
urin
sampl
collect
conveni
necropsi
dpi
camel
infecti
viru
viral
rna
detect
serum
whole
blood
sampl
small
quantiti
merscov
rna
detect
exhal
breath
qpcr
equivalentml
dpi
infecti
viru
detect
infecti
viru
detect
tissu
camel
euthan
dpi
tissu
obtain
camel
euthan
dpi
respect
infecti
viru
detect
tissu
upper
respiratori
tract
urt
includ
nasal
turbin
olfactori
epithelium
pharynx
larynx
lower
respiratori
tract
infecti
viru
detect
trachea
lung
lobe
test
infecti
viru
also
detect
retropharyng
mediastin
mesenter
tracheobronchi
lymph
node
figur
necropsi
camel
dpi
histolog
lesion
found
pseudostratifi
epitheli
cell
urt
lower
respiratori
tract
trachea
bronchi
bronchiol
alveoli
figur
lesion
character
mild
moder
acut
intraepitheli
submucos
inflamm
multifoc
necrosi
loss
pseudostratifi
epitheli
cell
compar
common
cold
among
human
multifoc
loss
epitheli
polar
cilia
squamou
metaplasia
observ
epithelium
infiltr
smalltomoder
number
neutrophil
fewer
macrophag
similar
inflammatori
cell
also
permeat
submucosa
submucos
gland
trachea
multifoc
necrot
infiltr
small
number
neutrophil
viral
antigen
detect
within
epitheli
cell
nasal
turbin
larynx
trachea
bronchi
bronchiol
alveoli
addit
viral
antigen
present
follicular
mantl
zone
tonsil
mediastin
retropharynch
lymph
node
figur
nasal
turbin
larynx
trachea
camel
necropsi
dpi
similar
milder
lesion
compar
camel
nasal
turbin
larynx
bronchu
show
small
number
infiltr
neutrophil
howev
contrast
condit
camel
cilia
goblet
cell
intact
remaind
respiratori
tract
camel
unaffect
immunohistochem
test
reveal
presenc
limit
viral
antigen
nasal
turbin
tissu
time
lesion
viral
antigen
detect
camel
dpi
serum
sampl
collect
weekli
camel
monitor
gener
neutral
antibodi
specif
mer
cov
camel
seroneg
inocul
robust
merscov
specif
antibodi
respons
develop
camel
euthan
dpi
respect
detect
first
dpi
plaquereduct
neutral
test
titer
increas
dpi
tabl
camel
euthan
dpi
test
develop
antibodi
viru
epidemiolog
surveil
data
emerg
merscov
strongli
point
toward
role
dromedari
camel
reservoir
zoonot
transmiss
understand
ecolog
merscov
like
reservoir
host
experiment
inocul
young
adult
dromedari
camel
mer
cov
diseas
observ
clinic
benign
agreement
absenc
overt
ill
report
field
surveil
studi
larg
quantiti
merscov
viral
rna
detect
nasal
swab
specimen
camel
infecti
viru
detect
dpi
rna
detect
dpi
camel
euthan
day
rout
shed
consist
data
natur
infect
camel
pattern
shed
suggest
infecti
period
camel
may
short
merscov
detect
either
urin
fece
consist
field
observ
larg
quantiti
merscov
shed
nasal
secret
camel
suggest
cameltocamel
cameltohuman
transmiss
may
occur
readili
direct
contact
larg
droplet
possibl
fomit
transmiss
histopatholog
examin
reveal
urt
specif
respiratori
epithelium
nasal
turbin
predomin
site
merscov
replic
camel
neutral
antibodi
detect
dpi
onward
reach
maximum
neutral
titer
day
serolog
studi
camel
field
report
merscov
neutral
titer
high
potenti
indic
repeat
exposur
reinfect
studi
report
done
basi
inocul
male
anim
human
isol
merscov
studi
design
use
impos
sever
limit
data
inform
occur
natur
infect
camel
inocul
expos
high
dose
viru
simultan
rout
inocul
retrospect
inocul
dose
seem
excess
base
larg
quantiti
viru
shed
nasal
anim
figur
total
dose
inocul
rel
equival
amount
viru
present
singl
nasal
swab
sampl
taken
first
day
postinocul
seem
probabl
camel
shed
quantiti
viru
would
readili
infect
camel
human
direct
contact
fact
inocul
camel
viru
rout
preclud
draw
conclus
regard
effici
transmiss
particular
rout
topic
address
futur
studi
influenc
camel
age
suscept
dynam
viru
shed
anoth
notabl
paramet
requir
studi
seem
like
product
infect
shed
viru
natur
set
occur
predominantli
juvenil
camel
could
result
intrins
differ
agerel
suscept
like
relat
immunolog
statu
anim
context
high
forc
infect
decay
passiv
acquir
antibodi
anim
infect
young
adult
seroneg
therefor
probabl
suscept
juvenil
region
anoth
aspect
pathogenesi
address
whether
viru
present
milk
meat
infect
camel
therebi
pose
anoth
potenti
rout
exposur
human
consum
product
despit
limit
magnitud
pattern
viru
shed
essenti
ident
anim
support
avail
epidemiolog
data
indic
camel
like
major
reservoir
host
merscov
addit
experiment
field
studi
clearli
requir
address
durat
shed
infecti
merscov
infect
camel
determin
whether
infect
result
protect
immun
clarifi
burden
ill
among
human
result
transmiss
camel
